Authors: Petit, B Leroy, K Kanavaros, P Boulland, ML Druet-Cabanac, M Haioun, C Bordessoule, D Gaulard, P

Citation: B. Petit et al., Expression of p53 protein in T- and natural killer-cell lymphomas is associated with some clinicopathologic entities but rarely related to p53 mutations, HUMAN PATH, 32(2), 2001, pp. 196-204

Authors: Kanavaros, P Boulland, ML Petit, B Arnulf, B Gaulard, P

Citation: P. Kanavaros et al., Expression of cytotoxic proteins in peripheral T-cell and natural killer-cell (NK) lymphomas: Association with extranodal site, NK or T gamma delta phenotype, anaplastic morphology and CD30 expression, LEUK LYMPH, 38(3-4), 2000, pp. 317-326

Authors: Bouloc, A Boulland, ML Geissmann, F Fraitag, S Andry, P Teillac, D Bensussan, A Revuz, J Boumsell, L Wechsler, J Bagot, M

Citation: A. Bouloc et al., CD101 expression by Langerhans cell histiocytosis cells, HISTOPATHOL, 36(3), 2000, pp. 229-232

Authors: Boulland, ML Wechsler, J Bagot, M Pulford, K Kanavaros, P Gaulard, P

Citation: Ml. Boulland et al., Primary CD30-positive cutaneous T-cell lymphomas and lymphomatoid papulosis frequently express cytotoxic proteins, HISTOPATHOL, 36(2), 2000, pp. 136-144

Authors: Kanavaros, P Vlychou, M Stefanaki, K Rontogianni, D Gaulard, P Pantelidaki, E Zois, M Darivianaki, K Georgoulias, V Boulland, ML Gorgoulis, V Kittas, C

Citation: P. Kanavaros et al., Cytotoxic protein expression in non-Hodgkin's lymphomas and Hodgkin's disease, ANTICANC R, 19(2A), 1999, pp. 1209-1216